Latest Addiction Medicine News
The Blavatnik Fund for Innovation at Yale, made possible by a generous grant from the Blavatnik Family Foundation, supports Yale faculty in the commercialization of biomedical and digital health innovations.
- May 09, 2023
Irene Chernova, MD, PhD, instructor of medicine (nephrology) has been selected as the recipient of the 2023 Iva Dostanic, MD, PhD, Physician-Scientist Trainee Award.
- April 30, 2023Source: The Washington Post
Ryan McNeil, PhD, associate professor of medicine (general medicine), comments on the challenge of tracking street drugs.
- April 20, 2023Source: The Washington Post
Ryan McNeil, PhD, associate professor of medicine (general medicine), weighs in on the price of overdose antidote Narcan.
- April 13, 2023
A new study across 28 emergency departments (EDs) with a high prevalence of fentanyl use has found that the incidence of a severe withdrawal reaction after use of buprenorphine is rare—less than one percent, a result that pleasantly surprised the researchers.
- April 11, 2023Source: Scientific American
Kimberly Sue, MD, PhD, assistant professor of medicine (general internal medicine), notes concerns about the price of an over-the-counter medicine that can help reverse opioid overdoses.
- March 24, 2023
In 2022, adolescents with a substance use disorder in Connecticut utilized emergency services at twice the rate of adults (18% versus 9%) with comparatively low engagement in lifesaving substance use disorder treatments (1%). The Yale Adolescent Addiction Medicine Consult Service and Adolescent Addiction Prevention Clinic are bringing critically needed services to teens and their families in hospital-based, outpatient, and school-based settings .
- March 21, 2023Source: CBS Chicago
The U.S. Drug Enforcement Administration issued a warning nationwide for the drug known as xylazine.
- March 21, 2023Source: WTNH News 8
Overdose deaths are dropping in Connecticut, according to early data from the state’s department of public health. The initial statistics show that confirmed overdose deaths fell 6% in 2022 compared to 2021, but leaders are still waiting on the final results.
- March 03, 2023Source: The New York Times
David Fiellin, MD, professor of medicine (general medicine), talks about the lifting of buprenorphine restrictions.